Antihypertensives

sartan serial

Candesartan cilexetil

Olmesartan medoxomil

Valsartan

Irbesartan

Losartan Potassium

Telmisartan

Pril serial

Perindopril erbumine

Quinapril hydrochloride

Fosinopril

Lisinopril

Ramipril

Benazepril hydrochloride

Enalapril Maleate

Captopril

Moexipril Hydrochloride

Temocapril

Cilazapril

Imidapril

Trandolapril

Ambrisentan

Bosentan

beta-blockers

Bisoprolol fumarate

Metoprolol

Carvedilol

Landiolol

Nebivolol

Esmolol

Labetalol

Celiprolol

Naftopidil

Diuretic

Hydrochlorothiazide

Amiloride

Vasodilator

Dihydralazine sulphate

Hydralazine hydrochloride

Calcium Antagonists

Amlodipine besylate

Cilnidipine

Clevidipine

Manidipine

Nicardipine

Felodipine

Nitrendipine

Nimodipine

Nisoldipine

Azelnidipine

Pranidipine

Benidipine

Nifedipine

Dilthiazem

Lercanidipine

Barnidipine

Eplerenone

Antianginals

Ivabradine

Isoamyl nitrite

Antithrombotics

Ethyl ferulate

Antibiotics

Ertapenem

Meropenem

Biapenem

Doripenem

Cefcapene pivoxil

Levofloxacin

Ofloxacin

Cephalosporins

Anti prostatic hyperplasias

Tamsulosin

Anticonvulsives

Pregabalin

Antiplatelet

Clopidogrel bisulfate

Prasugrel

Antileukemia

Clofarabine

Antiinflammatory

Loteprednol etabonate

Tenoxicam

Lornoxicam

Antihistamine

Azelastine Hydrochloride

Antineoplastic

Bicalutamide

Anticholinesterase

Pharmaceutical intermediates

Levocetirizine

Midazolam

4-(Diethylamino)salicylaldehyde

Pyrrolidine

Tetrazole

Triphenylphosphine

1-Pentyl-3-(1-naphthoyl)indole

1-Butyl-3-(1-naphthoyl)indole

2-Diphenylmethylpiperidine

Olivetol

1-Ethyl-3-pyrrolidinol

photoinitiator

Dyestuff

Treating High Systolic Blood Pressure Beneficial in Nondiabetic Patients

Beyond the Abstract - Medical Therapy to Facilitate the Passage of Stones

Resistant Escherichia coli Strains Put Emphasis on Selecting the Right Antibiotic for Critically Ill Patients

FDA Declines To Approve clofarabine As Treatment For Adult AML Patients

US Patent 6593492 - Resolution of intermediates in the synthesis of substantially pure bicalutamide-I

US Patent 6593492 - Resolution of intermediates in the synthesis of substantially pure bicalutamide-II